Vitamin K1 oil vs 1% powder: mass, carrier and the label
The oil is phytonadione at 97.0–103.0% by HPLC; the 1% powder is phytonadione dispersed on a carrier at 1.0–1.1%. The same 100 µg dose weighs about 0.1 mg as oil and about 10 mg as powder. That hundred-fold difference in mass is the whole comparison: it decides the dosage form, the process, the overage and what the label has to declare.
The oil is the molecule; the 1% powder is about 1% molecule with the rest carrier and moisture, so the same 100 µg dose weighs roughly a hundred times more.
The same dose, two masses
| Dose | Neat oil at about 100% | 1% powder |
|---|---|---|
| 75 µg (EU reference value) | About 0.075 mg | About 7.5 mg |
| 100 µg | About 0.1 mg | About 10 mg |
| 1 mg | About 1 mg | About 100 mg |
The oil figure is the vitamin itself; the powder figure includes the carrier. On a softgel line the oil is diluted into a carrier oil before the fill, because 0.1 mg cannot be weighed as a single dose; that dilution is a separate blend with its own specification. On a capsule or tablet line the powder is weighed as a premix: 10 mg of the 1% powder is about 2% of a 500 mg capsule, and the rest of the fill is other actives and excipients.
At a 1 mg claim the powder is 100 mg, or 20% of the same capsule, and the carrier starts to take up space the formula may not have. The mass, not the potency, is what limits the format.
The carrier is part of the product
The oil is the molecule and nothing else; the powder is the molecule plus a matrix. The catalog record fixes the declared content at 1.0–1.1% and names the form as phytonadione on a carrier, but the carrier is not a formality. It is chosen by the manufacturer and written into the specification and the technical data sheet.
The common families are a carbohydrate matrix such as maltodextrin, a gum such as acacia, and a mineral carrier such as silicon dioxide or calcium phosphate. Some grades add an antioxidant. Each choice changes the flow, the dispersibility, the moisture sensitivity and the label: a cereal-derived carrier can bring an allergen or gluten statement, a maize-derived one can bring a GMO statement, and an antioxidant is an ingredient whose declaration and level need checking.
A carrier change is a specification change even when the assay stays at 1.0%. It needs a new technical data sheet, a label check and a stability check. The oil has no carrier line, which is one reason an oil fill is simpler on paper.
Overage costs mass on a 1% powder
An overage is a finished-product decision: the brand adds vitamin above the label claim to cover loss over shelf life. On the oil, a 10% overage adds 0.01 mg to a 100 µg dose — a quantity that disappears in the fill. On the 1% powder, the same overage adds 1 mg of powder at 100 µg and 10 mg at 1 mg, and that mass has to fit the capsule or the sachet.
Overage also changes the carrier intake and the label arithmetic: the declared vitamin goes up, the carrier goes up with it, and the ingredient list does not change but the amount per serving does. The 1.0–1.1% assay window is not an overage; it is the release range of the ingredient, and the two should not be conflated.
A formulator who needs an overage should check that the powder's mass still fits the dosage form before writing it into the label. The overage does not repair a pack that lets light or moisture in.
Two forms, two processes
The oil suits softgels, oil blends and emulsions. It needs warmed lines, a nitrogen blanket and an amber or opaque pack, and it is measured by mass into an oil phase. The powder suits tablets, capsule blends, stick packs and dry mixes. It needs a blending step, dust control and a content-uniformity check, and it is measured as a premix into a powder blend.
An aqueous drink is the wrong place for the oil unless it is emulsified; the powder disperses in water but does not dissolve, so a clear drink is still an emulsion project. Neither form is a drop-in for the other: the process, the equipment and the quality checks change with the form.
The powder also changes the failure mode. An oil lot fails on light, oxygen and the bottle seal; a powder lot can fail on moisture, caking and segregation, and a segregated blend can pass the composite assay while the capsule does not. The quality plan follows the form.
What the label has to declare
Both forms declare vitamin K as phytonadione, for example “Vitamin K (as phytonadione)”, and both calculate the percentage against the same reference value: 75 µg in the EU and 120 µg in the US, as of this review. The difference is what else appears on the label.
The powder adds the carrier to the ingredient list, and the carrier may bring an allergen, gluten or GMO statement. The oil adds no carrier unless it has been blended into a carrier oil, in which case that oil is declared too. A label written for the oil is not correct for the powder, and the reverse is also true: the ingredient list, the mass per serving and the % NRV or % DV all follow the form.
The label name is not a marketing choice. A panel that says only “vitamin K” has not identified the form, and a panel that says “phytonadione” has not disclosed the carrier in the powder. Both lines are needed, and they have to match the certificate and the specification revision.
When to choose which
Choose the oil when the dosage form is a softgel, an oil blend or an emulsion, and when the plant has the handling for it. Choose the powder when the line is dry, when the dose is large enough for the powder mass to fit, or when the formula is a blend in which 10–100 mg of powder is a minor component.
Choose neither by habit. A 100 µg single-ingredient capsule is a poor fit for the 1% powder, because 10 mg is below a practical fill; a 1 mg tablet blend can use the powder comfortably. If the form changes, the specification, the label and the stability file change with it.
The powder's catalog specification is on the vitamin K1 1% powder page, and the oil's is on the vitamin K1 page. The grades page compares the milled and granulated finishes; the COA page shows how the powder is released; the methods library describes the HPLC assay; the quality page covers the release file.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation